Why patients should be more empowered: A European perspective on lessons learned in the management of diabetes

Journal of Diabetes Science and Technology

Volumn 4, Issue 6, 2010, Pages 1570-1573

  Chatzimarkakis, Jorgo ^a  

^a European Parliament   (Belgium)

Author keywords

Patient empowerment

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; ATTITUDE TO HEALTH; BEHAVIOR; BLOOD; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; EUROPE; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; PATIENT EDUCATION; PATIENT PARTICIPATION; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; EUROPE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; POWER (PSYCHOLOGY); TREATMENT OUTCOME;

EID: 79953008371     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400634     Document Type: Note

References (24)

1. Vassiliou, A. European Patient's Rights Day. Speech presented at: European Union Patient's Rights Day; April 22, 2009; Strasbourg, Austria. Available from: http://ec.europa.eu/dgs/health-consumer/dyna/mailbox/index-en. cfmon.
2. Monteagudo Pena JL, Moreno Gil O. e-Health for patient empowerment in Europe. Madrid: Instituto de Salud Carlos III, 2007. Available from: http://ec.europa.eu/information-society/activities/health/docs/publications/ eh-era-patient-empower.pdf.
3. Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B; ASIA Group. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab. 2003;29(7614):587-94.
4. Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M, Imamoglu S, Perusicová J, Uliciansky V, Winkler G. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab. 2008;10(12):1239-47.
5. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia. 2006;49(2):271-8.
6. St. John A, Davis WA, Price CP, Davis TME. The value of self-monitoring of blood glucose: a review of recent evidence. J Diabetes Complications. 2010;24(2):129-41.
7. Kempf K, Kruse J, Martin S. ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus. Diabetes Technol Ther. 2010;12(7):547-53.
8. Schwedes U, Siebolds M, Mertes G; SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25(11):1928-32.
9. Klonoff D. New evidence demonstrates that self-monitoring of blood glucose does not improve outcomes in type 2 diabetes-when this practice is not applied properly. J Diabetes Sci Technol. 2008;2(3):342-8.
10. Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, Grzeszczak W, Harno K, Kempler P, Satman I, Vergès B. Consensus statement on self-monitoring of blood glucose in diabetes [in German]. Diabetes Stoffwechsel und Herz. 2009;Band 18:285-9.
11. Parkin CG, Davidson JA. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol. 2009;3(3):500-8.
12. Polonsky W, Fisher L. Accu-Chek® 360° view outcome study: introduction, study design and first results. Paper presented at: The EASD-Congress; September 2009; Vienna. Available from: http://easd. conference2web.com/play/2009/200049.
13. Weber C, Neeser K, Lodwig V, Schneider B. Self-measurement of blood glucose in patients with type 2 diabetes: a health economic assessment. J Diabetes Sci Technol. 2007;1(5):676-84.
14. Tunis SL, Minshall ME. Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the United States. Am J Manag Care. 2008;14(3):131-140.
15. Gray A Raikou M, McGuire A, Fenn P, Stevens R, Cull C, Stratton I, Adler A, Holman R, Turner R. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomized controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ. 2000;320(7246):1373-8.
16. Clinical Guidelines Task Force. Global guideline for type 2 diabetes. International Diabetes Federation; 2005; Brussels, Belgium. Available from: http://www.idf.org/webdata/docs/IDF%20GGT2D.pdf.
17. Consensus Conference committees. Guideline: self-monitoring of blood glucose in non-insulin treated type 2 diabetes. International Diabetes Federation; 2009; Brussels, Belgium. Available from: http://www.idf.org/webdata/ docs/SMBG-EN2.pdf.
18. The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). Royal College of Physicians; 2008; London. Available from: http://www.nice.org.uk/nicemedia/pdf/CG66diabetesfullguideline.pdf.
19. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J FESC, Priori SG, Pyorala K, Reiner Z, Ruilope LM, Sans-Menendez S, Scholte Op Reimer W, Weissberg P, Wood DA, Yarnell J, Zamorano JL. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease management and prevention in clinical practice. Eur J Cardiovasc Prev Rehabil. 2007;14(Suppl 2):S1-113.
20. American Diabetes Association. Position Statement. Standards of Medical Care in Diabetes-2010. Diabetes Care. 2010;33(Suppl 1):S11-61. Available from: http://care.diabetesjournals.org/content/33/Supplement-1/S11.full.
21. International Diabetes Federation Europe. EU Diabetes Working Group. Available from: http://www.idf.org/EU-DWG.
22. Chatzimarkakis, J. Patient empowerment-a new paradigm in disease management? Presented at: European Life Science Circle; March 2, 2010; European Parliament, Brussels, Belgium. Available from: http://jorgochatzimarkakis. english.org.liberale.de/meldung.php?id=60902&pid=97858.
23. Kaptein AA, Klonoff DC, Martin S, Meyhoff M, Stock S, Jumiss J, Buzemaniene L, Zillén PA. Meeting the challenge of chronic diseases: the role of patient empowerment and self-management. Presented at: European Life Science Circle; March 2, 2010; European Parliament, Brussels, Belgium. Available from: http://jorgochatzimarkakis.org.liberale.de/sitefiles/downloads/928/ELSC- Empowerment-Rec.pdf
24. Klonoff D Bergenstal R, Blonde L, Boren SA, Church TS, Gaffaney J, Jovanovic L, Kendall DM, Kollman C, Kovatchev BP, Leippert C, Owens DR, Polonsky WH, Reach G, Renard E, Riddell MC, Rubin RR, Schnell O, Siminiero LM, Vigersky RA, Wilson DM, Wollitzer AO. Consensus report of the coalition for clinical research-self-monitoring of blood glucose. J Diabetes Sci Technol. 2008:2(6);1030-53.